Asia Pacific Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers APAC Blood Glucose Monitoring Market Overview & Outlook and the Market is Segmented by Self-Monitoring Blood Glucose Devices (glucometer Devices, Test Strips, and Lancets), Continuous Glucose Monitoring Devices (sensors and Durables), End Users (Hospital/Clinics and Home/Personal), and Geography (Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand, and Rest of Asia - Pacific). the Market Provides the Value (in USD) and Volume (in Unit) for the Above-Mentioned Segments.

Asia Pacific Blood Glucose Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Asia-Pacific Blood Glucose Monitoring Market Size

View Global Report
Asia-Pacific Blood Glucose Monitoring Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
Market Size (2025) USD 4.06 Billion
Market Size (2030) USD 5.88 Billion
CAGR (2025 - 2030) 7.69 %

Major Players

Asia-Pacific Blood Glucose Monitoring Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Asia-Pacific Blood Glucose Monitoring Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Asia-Pacific Blood Glucose Monitoring Market Analysis

The Asia-Pacific Blood Glucose Monitoring Market size is estimated at USD 4.06 billion in 2025, and is expected to reach USD 5.88 billion by 2030, at a CAGR of 7.69% during the forecast period (2025-2030).

The growth of the Asia-Pacific Diabetes Care Devices Market was positively influenced by the COVID-19 pandemic. Individuals with diabetes who contracted COVID-19 may experience higher blood glucose levels, abnormal glucose fluctuations, and diabetic complications. The presence of diabetes in individuals with COVID-19 led to a significant increase in the severity and mortality of the virus, particularly in those with type 1 (T1DM) or type 2 diabetes mellitus (T2DM) and poor glycemic control. Additionally, the onset of hyperglycemia and diabetes (both T1DM and T2DM) has been increasingly observed in the context of COVID-19 and has been linked to worse outcomes. 

Regular monitoring of a patient's blood glucose levels is crucial to prevent exacerbation, highlighting the importance of blood glucose monitoring devices. The pandemic emergency has resulted in a surge in remote care from both patients and healthcare providers, along with the removal of various longstanding regulatory barriers.

Asia-Pacific has countries with the highest diabetic populations, such as China and India, with an average prevalence rate of more than 8.5%. Blood glucose monitoring devices are used for effective diabetes diagnosis and treatment. A rise in the diabetic population drives the market by increasing the use of blood glucose monitoring devices. Obesity is also considered one of the major factors contributing to the disease condition, mainly type 2 diabetes. Also, other factors such as technological innovations and advances provide convenience in measuring blood glucose levels. These devices help in the early detection of hypo- and hyperglycemic conditions, which tend to drive the market for glucose monitoring market.

The incidence of newly diagnosed cases of Type 1 and Type 2 diabetes is observed to be on the rise, primarily due to factors such as obesity, unhealthy diet, and lack of physical activity. This increase in diabetes cases, along with the corresponding rise in healthcare expenditure, is indicative of the growing utilization of diabetic care products in developed countries. Additionally, the market growth is being driven by the increasing adoption of insulin delivery devices and the escalating prevalence of diabetes. To capture a significant market share, leading manufacturers are focusing on technological advancements and the development of advanced products. As a result of these factors, the analyzed market is expected to experience growth during the specified period of analysis.

Asia-Pacific Blood Glucose Monitoring Industry Overview

The Asia-Pacific Blood Glucose Monitoring Market is moderately fragmented, with few major manufacturers, including a presence in major countries of the Asia-Pacific market. In contrast, the remaining manufacturers stayed confined to the other local or region-specific markets. Mergers and acquisitions between players in the recent past helped companies strengthen their market presence.

Asia-Pacific Blood Glucose Monitoring Market Leaders

  1. Roche

  2. Medtronics

  3. Dexcom

  4. Abbott Diabetes Care

  5. Johnson & Johnson

  6. *Disclaimer: Major Players sorted in no particular order
Asia-Pacific Blood Glucose Monitoring Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Asia-Pacific Blood Glucose Monitoring Market News

  • FEB 2023: Dexcom G6 Continuous Glucose Monitoring System was launched in Singapore.
  • MAR 2022: Quantum Operation Inc., a Tokyo-based healthcare IoT startup, presented the world's first non-invasive glucose monitor capable of continuous measurement. It measures the blood sugar from the wrist without any pricks.

Asia-Pacific Blood Glucose Monitoring Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
  • 4.3 Market Restraints
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 Self-monitoring Blood Glucose Devices
    • 5.1.1 Glucometer Devices
    • 5.1.2 Test Strips
    • 5.1.3 Lancets
  • 5.2 Continuous Glucose Monitoring Devices
    • 5.2.1 Sensors
    • 5.2.2 Durables
  • 5.3 By End User
    • 5.3.1 Hospital/Clinics
    • 5.3.2 Home/Personal
  • 5.4 Geography
    • 5.4.1 Japan
    • 5.4.2 South Korea
    • 5.4.3 China
    • 5.4.4 India
    • 5.4.5 Australia
    • 5.4.6 Vietnam
    • 5.4.7 Malaysia
    • 5.4.8 Indonesia
    • 5.4.9 Philippines
    • 5.4.10 Thailand
    • 5.4.11 Rest of Asia-Pacific

6. MARKET INDICATORS

  • 6.1 Type-1 Diabetes Population
  • 6.2 Type-2 Diabetes Population

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles
    • 7.1.1 Abbott Diabetes Care
    • 7.1.2 Roche
    • 7.1.3 Dexcom
    • 7.1.4 Medtronic
    • 7.1.5 Johnson and Johnson (Lifescan)
    • 7.1.6 Arkray
    • 7.1.7 Ascensia Diabetes Care
    • 7.1.8 Agamatrix Inc.
    • 7.1.9 Bionime Corporation
    • 7.1.10 Acon
    • 7.1.11 Medisana
    • 7.1.12 Trivida
    • 7.1.13 Rossmax
  • *List Not Exhaustive
  • 7.2 Company Share Analysis
    • 7.2.1 Self-Monitoring Blood Glucose Devices
    • 7.2.1.1 Abbott Diabetes Care
    • 7.2.1.2 Roche
    • 7.2.1.3 Others
    • 7.2.2 Continuous Glucose Monitoring Devices
    • 7.2.2.1 Dexcom
    • 7.2.2.2 Medtronic
    • 7.2.2.3 Abbott Diabetes Care
    • 7.2.2.4 others

8. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
* We will provide a segment-wise breakdown (Value and Volume) for all the countries covered under the Table of Contents. **Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments.
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Asia-Pacific Blood Glucose Monitoring Industry Segmentation

If available, glucose can be tested with fingersticks, a glucose meter, or a continuous glucose monitoring (CGM) device. The use of CGM devices is increasing, especially for people who use an insulin pump or multiple daily insulin injections. The two main types of blood glucose monitoring devices are included in this study. These devices are further categorized into self-monitoring blood glucose (SMBG) devices (segmented into glucometer devices, test strips, and lancets), continuous glucose monitoring (CGM) devices segmented into sensors and durables, and geography segmented into Japan, South Korea, China, India, Australia, Vietnam, Malaysia, Indonesia, Philippines, Thailand, and rest of Asia-Pacific and End Users (Hospital/Clinics and Home/Personal),. The report provides a detailed analysis of the use and demand for glucose monitoring devices in Asia-Pacific. The report offers the value (in USD) and volume (in units) for the above segments. We will provide a segment-wise breakdown (value and volume) for all the countries covered under the Table of Contents.

Self-monitoring Blood Glucose Devices Glucometer Devices
Test Strips
Lancets
Continuous Glucose Monitoring Devices Sensors
Durables
By End User Hospital/Clinics
Home/Personal
Geography Japan
South Korea
China
India
Australia
Vietnam
Malaysia
Indonesia
Philippines
Thailand
Rest of Asia-Pacific
Need A Different Region or Segment?
Customize Now

Asia-Pacific Blood Glucose Monitoring Market Research FAQs

How big is the Asia-Pacific Blood Glucose Monitoring Market?

The Asia-Pacific Blood Glucose Monitoring Market size is expected to reach USD 4.06 billion in 2025 and grow at a CAGR of 7.69% to reach USD 5.88 billion by 2030.

What is the current Asia-Pacific Blood Glucose Monitoring Market size?

In 2025, the Asia-Pacific Blood Glucose Monitoring Market size is expected to reach USD 4.06 billion.

Who are the key players in Asia-Pacific Blood Glucose Monitoring Market?

Roche, Medtronics, Dexcom, Abbott Diabetes Care and Johnson & Johnson are the major companies operating in the Asia-Pacific Blood Glucose Monitoring Market.

What years does this Asia-Pacific Blood Glucose Monitoring Market cover, and what was the market size in 2024?

In 2024, the Asia-Pacific Blood Glucose Monitoring Market size was estimated at USD 3.75 billion. The report covers the Asia-Pacific Blood Glucose Monitoring Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Asia-Pacific Blood Glucose Monitoring Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Asia-Pacific Blood Glucose Monitoring Industry Report

Statistics for the 2025 Asia-Pacific Blood Glucose Monitoring market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Blood Glucose Monitoring analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.